Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Occlusion can be beneficial in inflammatory skin disease such as psoriasis but may be detrimental in atopic dermatitis. Filaggrin deficits in atopic dermatitis make skin more likely to fissure ...

Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the publication of a case study highlighting the use of ...

SciBase is excited to announce a new collaboration aimed at revolutionizing early detection of atopic diseases in infants through the use of Electrical Impedance Spectroscopy (EIS) technology. This ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...

Dermatologists have warned that applying adult skincare products and alcohol-based creams on babies puts them at risk of skin ...

Nonetheless, significant recent data suggest that the status of the skin barrier may also impact on disease expression. The discovery of the association of FLG mutations with atopic diseases ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...

About 31.6 million, or 10% of all people in the United States, have some form of eczema, also called atopic dermatitis. It affects people of all ethnicities and skin colors. Of all Americans with ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.